PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding PolyPid Ltd. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 5 | 8 | +3 |
| Shares | 20.9K | 1.10M | +1.08M (+5,154.5%) |
| Value | $79.6K | $5.13M | +$5.05M (+6,348.9%) |
New holders (3)
Institutions that held PolyPid Ltd. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AIGH Capital Management LLC | 479,246 | $2.27M | 1.10% |
| Rosalind Advisors, Inc. | 415,800 | $1.91M | 1.79% |
| DAFNA Capital Management LLC | 185,446 | $853.1K | 0.19% |
Sold out (0)
Institutions that held PolyPid Ltd. at the end of Q4 2023 and filed for Q1 2024 without it.
None.